Pfanstiehl is globally recognized as a leader in manufacturing cGMP high-purity, low-endotoxin, low-metal injectable-grade excipients and biopharmaceutical components for various applications in bioprocessing, formulation, and specialty areas. Additionally, Pfanstiehl operates as a prominent contract development and manufacturing organization (CDMO), specializing in the isolation, purification, custom synthesis, and scale-up development of small molecule Active Pharmaceutical Ingredients (APIs)...ranging from gram to multi-ton commercial quantities. While many ingredient manufacturers or resellers cater to various industries like food, cosmetics, agriculture, and nutritional supplements, providing only a limited range of “pharma-grade” ingredients, Pfanstiehl's exclusive focus lies in Biopharma applications, demonstrating a dedicated commitment to this specific sector
